IMEGLIMIN Imeglimin is an experimental drug being developed as - TopicsExpress



          

IMEGLIMIN Imeglimin is an experimental drug being developed as an oral anti-diabetic. It is an oxidative phosphorylation blocker that acts to inhibit hepatic gluconeogenesis, increase muscle glucose uptake, and restore normal insulin secretion. It will be the first of a new class of anti-diabetic if it is approved. Imeglimin is in development (phase IIa clinical trials) for use both as monotherapy and in combination with other type-2 diabetes treatments. Various research protocols are being known through various scientists. Early studies showed that imeglimin is as effective as metformin in regulating glycaemic control
Posted on: Thu, 24 Apr 2014 03:04:03 +0000

Trending Topics



Recently Viewed Topics




© 2015